Pharmaceutical manufacturing in Sub-Saharan Africa is – contrary to external perceptions – long established. African governments, as well as regional and international institutions are actively promoting industrial development in pharmaceuticals in Sub-Saharan Africa countries. At the same time, low income populations suffer inadequate health care undermined by poor access to medicines.
Within African contexts, there is now strong recognition that there are potentially large developmental synergies to be extracted between expansion of local pharmaceutical production and improvement of health care systems. However, in international research and policy debates, health system strengthening and industrial development have been largely addressed within two separate silos. A newly presented Evidence Brief therefore investigates the linkages – positive and negative – between local industrial production and the strengthening of health systems in Africa. Furthermore, suggestions are made on how development partners can support the upward spiral of industry-health synergies. Last but not least, the document illustrates that both local and global perspectives on emergency preparedness need to be considered to build medium-term health security.
The Evidence Brief is a publication in the German Health Practice Collection, a joint initiative of the German Federal Ministry for Economic Cooperation (BMZ) and its implementing agencies, the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH and KfW Development Bank (KfW).